These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1299 related items for PubMed ID: 23045275

  • 1. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z, Li Q, Li K, Chen L, Li W, Hou M, Liu T, Yang J, Lindvall C, Björkholm M, Jia J, Xu D.
    Oncogene; 2013 Sep 05; 32(36):4203-13. PubMed ID: 23045275
    [Abstract] [Full Text] [Related]

  • 2. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
    Qin Y, Tang B, Hu CJ, Xiao YF, Xie R, Yong X, Wu YY, Dong H, Yang SM.
    Oncotarget; 2016 Jan 05; 7(1):351-61. PubMed ID: 26540342
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
    Choi YJ, Kim N, Chang H, Lee HS, Park SM, Park JH, Shin CM, Kim JM, Kim JS, Lee DH, Jung HC.
    Carcinogenesis; 2015 May 05; 36(5):553-63. PubMed ID: 25784376
    [Abstract] [Full Text] [Related]

  • 4. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
    Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H, Yang Q, Jia J.
    Clin Cancer Res; 2013 Dec 01; 19(23):6419-29. PubMed ID: 24077348
    [Abstract] [Full Text] [Related]

  • 5. TGF-β-mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells.
    Jaiswal RK, Yadava PK.
    Biofactors; 2019 Sep 01; 45(5):803-817. PubMed ID: 31317567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X, Wang B, Wang X, Luo Y, Fan W.
    PLoS One; 2018 Sep 01; 13(4):e0192436. PubMed ID: 29689047
    [Abstract] [Full Text] [Related]

  • 8. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK, Hu J, Li T, Meng JR, Ma X, Yin SJ, Zhao CH, He GH, Xu GL.
    Eur J Cancer; 2014 Apr 01; 50(6):1195-206. PubMed ID: 24447834
    [Abstract] [Full Text] [Related]

  • 9. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A.
    Cancer Res; 2005 Dec 15; 65(24):11649-57. PubMed ID: 16357176
    [Abstract] [Full Text] [Related]

  • 10. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
    Zhao J, Yang C, Guo S, Wu Y.
    Int J Clin Exp Pathol; 2015 Dec 15; 8(9):10784-91. PubMed ID: 26617790
    [Abstract] [Full Text] [Related]

  • 11. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
    Zhao W, Jia L, Kuai X, Tang Q, Huang X, Yang T, Qiu Z, Zhu J, Huang J, Huang W, Feng Z.
    Cancer Med; 2019 Mar 15; 8(3):1135-1147. PubMed ID: 30632714
    [Abstract] [Full Text] [Related]

  • 12. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 15; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 13. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y, Toh L, Lau P, Wang X.
    J Biol Chem; 2012 Sep 21; 287(39):32494-511. PubMed ID: 22854964
    [Abstract] [Full Text] [Related]

  • 14. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS, Park DJ, Kim HH, Kim WH, Lee HS.
    Hum Pathol; 2012 Apr 21; 43(4):520-8. PubMed ID: 22018628
    [Abstract] [Full Text] [Related]

  • 15. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H, Farhat WA.
    Mol Carcinog; 2016 May 21; 55(5):537-51. PubMed ID: 25728352
    [Abstract] [Full Text] [Related]

  • 16. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T.
    Cancer Lett; 2014 Dec 01; 355(1):130-40. PubMed ID: 25218351
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL, Luo GQ, Yang XJ, Xiao N, Xie B, Xiao H, Liu RJ, Dong CS, Wang KS, Wen JF.
    PLoS One; 2014 Dec 01; 9(6):e99922. PubMed ID: 24945379
    [Abstract] [Full Text] [Related]

  • 18. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH, Kim G, Kwon CI, Kim JW, Park PW, Hahm KB.
    Oncol Rep; 2014 Mar 01; 31(3):1380-8. PubMed ID: 24402192
    [Abstract] [Full Text] [Related]

  • 19. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B, Chen Q, Cao Y, Ma X, Yin C, Jia Y, Zang A, Fan W.
    PLoS One; 2016 Mar 01; 11(12):e0168904. PubMed ID: 28033430
    [Abstract] [Full Text] [Related]

  • 20. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R, Zhu J, Dong Y, He C, Hu X.
    Oncotarget; 2015 Oct 20; 6(32):32841-55. PubMed ID: 26418880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.